Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2013

Open Access 01-12-2013 | Original investigation

Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up

Authors: Salvatore Novo, Angelica Peritore, Rosaria Linda Trovato, Francesco Paolo Guarneri, Daniela Di Lisi, Ida Muratori, Giuseppina Novo

Published in: Cardiovascular Diabetology | Issue 1/2013

Login to get access

Abstract

Background

Intima-media thickness (IMT) is a validated marker of preclinical atherosclerosis and a predictor of cardiovascular events.

Patients

We studied a population of 529 asymptomatic patients (age 62 ± 12.8 years), divided into two groups of subjects with and without Metabolic Syndrome (MetS).

Methods

All patients, at baseline, have had a carotid ultrasound evaluation and classified in two subgroups: the first one without atherosclerotic lesions and the second one with preclinical atherosclerosis (increased IMT or asymptomatic carotid plaque). Cardiovascular endpoints were investigated in a 20-years follow-up.

Results

There were 242 cardiovascular events: 144 among patients with MetS and 98 among in healthy controls (57.4% vs. 35.2%; P < 0.0001). 63 events occurred in patients with normal carotid arteries, while 179 events occurred in patients with preclinical atherosclerosis (31.8% vs. 54.1%; P < 0.0001). Of the 144 total events occurred in patients with MetS, 36 happened in the subgroup with normal carotid arteries and 108 in the subgroup with preclinical atherosclerosis (45% vs. 63.15%; P = 0.009). 98 events occurred in patients without MetS, of which 27 in the subgroup with normal carotid arteries and 71 in the subgroup with preclinical atherosclerosis (22.88% vs. 44.37%; P = 0.0003). In addition, considering the 63 total events occurred in patients without atherosclerotic lesions, 36 events were recorded in the subgroup with MetS and 27 events in the subgroup without MetS (45% vs. 22.88%; P = 0.0019). Finally, in 179 total events recorded in patients with preclinical carotid atherosclerosis, 108 happened in the subgroup with MetS and 71 happened in the subgroup without MetS (63.15% vs. 44.37%; P = 0.0009). The Kaplan-Meier function showed an improved survival in patients without atherosclerotic lesions compared with patients with carotid ultrasound alterations (P = 0.01, HR: 0.7366, CI: 0.5479 to 0.9904).

Conclusions

Preclinical atherosclerosis leads to an increased risk of cardiovascular events, especially if it is associated with MetS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dahl-Jørgensen K, Larsen JR, Hanssen KF: Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?. Diabetologia. 2005, 48: 1445-1453.CrossRefPubMed Dahl-Jørgensen K, Larsen JR, Hanssen KF: Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?. Diabetologia. 2005, 48: 1445-1453.CrossRefPubMed
2.
go back to reference Panayiotou AG, Griffin M, Kouis P, Tyllis T, Georgiou N, Bond D, Nicolaides AN: Association between presence of the metabolic syndrome and its components with carotid intima-media thickness and carotid and femoral plaque area: a population study. Diabetol Metab Syndr. 2013, 5 (1): 44.PubMedCentralCrossRefPubMed Panayiotou AG, Griffin M, Kouis P, Tyllis T, Georgiou N, Bond D, Nicolaides AN: Association between presence of the metabolic syndrome and its components with carotid intima-media thickness and carotid and femoral plaque area: a population study. Diabetol Metab Syndr. 2013, 5 (1): 44.PubMedCentralCrossRefPubMed
3.
go back to reference Koskinen J, Kahonen M, Viikari JSM: Conventional CV risk factors and MetS in predicting carotid intima-media thickness progression in young adults. The CV risk in young Finns study. Circulation. 2009, 120: 229-236.CrossRefPubMed Koskinen J, Kahonen M, Viikari JSM: Conventional CV risk factors and MetS in predicting carotid intima-media thickness progression in young adults. The CV risk in young Finns study. Circulation. 2009, 120: 229-236.CrossRefPubMed
4.
go back to reference Heiss G, Sharrett AR, Barnes R: Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991, 134: 250-256.PubMed Heiss G, Sharrett AR, Barnes R: Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991, 134: 250-256.PubMed
5.
go back to reference Lande MB, Carson NL, Roy J: Effects of childhood primary hypertension on carotid intima media thickness. A matched controlled study. Hypertension. 2006, 48: 40-44.CrossRefPubMed Lande MB, Carson NL, Roy J: Effects of childhood primary hypertension on carotid intima media thickness. A matched controlled study. Hypertension. 2006, 48: 40-44.CrossRefPubMed
6.
go back to reference Puato M, Palatini P, Zanardo M: Increase in carotid intima-media thickness in grade I hypertensive subjects. White-coat versus sustained hypertension. Hypertension. 2008, 51: 1300-1305.CrossRefPubMed Puato M, Palatini P, Zanardo M: Increase in carotid intima-media thickness in grade I hypertensive subjects. White-coat versus sustained hypertension. Hypertension. 2008, 51: 1300-1305.CrossRefPubMed
7.
go back to reference Milio G, Corrado E, Novo S: Asymptomatic carotid lesions and aging: Role of hypertension and other traditional and emerging risk factors. Arch Med Res. 2006, 37: 342-347.CrossRefPubMed Milio G, Corrado E, Novo S: Asymptomatic carotid lesions and aging: Role of hypertension and other traditional and emerging risk factors. Arch Med Res. 2006, 37: 342-347.CrossRefPubMed
8.
go back to reference Brohall G, Oden A, Fagerberg B: Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med. 2006, 23: 609-616.CrossRefPubMed Brohall G, Oden A, Fagerberg B: Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med. 2006, 23: 609-616.CrossRefPubMed
9.
go back to reference Linnebank M, Moskau S, Farmand S: Homocysteine and carotid intima-media thickness in a German population: lack of clinical relevance. Stroke. 2006, 37: 2840-2842.CrossRefPubMed Linnebank M, Moskau S, Farmand S: Homocysteine and carotid intima-media thickness in a German population: lack of clinical relevance. Stroke. 2006, 37: 2840-2842.CrossRefPubMed
10.
go back to reference Thakore AH, Guo CY, Larson MG: Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol. 2007, 99: 1598-1602.CrossRefPubMed Thakore AH, Guo CY, Larson MG: Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol. 2007, 99: 1598-1602.CrossRefPubMed
11.
go back to reference Tavil Y, Kaya MG, Oktar SO: Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis. 2008, 197: 159-163.CrossRefPubMed Tavil Y, Kaya MG, Oktar SO: Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis. 2008, 197: 159-163.CrossRefPubMed
12.
go back to reference Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106: 3143-3421. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106: 3143-3421.
13.
go back to reference Novo S, Balbarini A, Belch JJ: The metabolic syndrome: definition, diagnosis and management. Int Angiol. 2008, 27: 220-231.PubMed Novo S, Balbarini A, Belch JJ: The metabolic syndrome: definition, diagnosis and management. Int Angiol. 2008, 27: 220-231.PubMed
14.
go back to reference Novo G, Corrado E, Muratori I, Novo S: Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome. Int Angiol. 2007, 26: 312-317.PubMed Novo G, Corrado E, Muratori I, Novo S: Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome. Int Angiol. 2007, 26: 312-317.PubMed
15.
go back to reference Ford E, Giles W, Dietz W: Prevalence of the metabolic syndrome among U.S. adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359.CrossRefPubMed Ford E, Giles W, Dietz W: Prevalence of the metabolic syndrome among U.S. adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359.CrossRefPubMed
16.
go back to reference Reaven GM: Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988, 37: 1595-1607.CrossRefPubMed Reaven GM: Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988, 37: 1595-1607.CrossRefPubMed
17.
go back to reference Kawamoto R, Tomita H, Inoue A, Ohtsuka N, Kamitani A: Metabolic syndrome may be a risk factor for early carotid atherosclerosis in women but not in men. J Atheroscler Thromb. 2007, 14: 36-43.CrossRefPubMed Kawamoto R, Tomita H, Inoue A, Ohtsuka N, Kamitani A: Metabolic syndrome may be a risk factor for early carotid atherosclerosis in women but not in men. J Atheroscler Thromb. 2007, 14: 36-43.CrossRefPubMed
18.
go back to reference NcNeill AM, Rosamond WD, Girman CJ: Prevalence of coronary heart disease and carotid thickening in patients with metabolic syndrome (the ARIC study). Am J Cardiol. 2004, 94: 1249-1254.CrossRef NcNeill AM, Rosamond WD, Girman CJ: Prevalence of coronary heart disease and carotid thickening in patients with metabolic syndrome (the ARIC study). Am J Cardiol. 2004, 94: 1249-1254.CrossRef
19.
go back to reference Scuteri A, Najjar SS, Muller DC, Andres: Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004, 43: 1388-1395.CrossRefPubMed Scuteri A, Najjar SS, Muller DC, Andres: Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004, 43: 1388-1395.CrossRefPubMed
20.
go back to reference Tzou WS, Douglas PS, Srinivasan SR: Increased preclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa heart study. J Am Coll Cardiol. 2005, 46: 457-463.CrossRefPubMed Tzou WS, Douglas PS, Srinivasan SR: Increased preclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa heart study. J Am Coll Cardiol. 2005, 46: 457-463.CrossRefPubMed
21.
go back to reference Sipila K, Moilanem L, Nieminen T: Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis. 2009, 204: 276-281.CrossRefPubMed Sipila K, Moilanem L, Nieminen T: Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis. 2009, 204: 276-281.CrossRefPubMed
22.
go back to reference Novo S, Peritore A, Guarneri FP: Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study. Atherosclerosis. 2012, 223: 468-472.CrossRefPubMed Novo S, Peritore A, Guarneri FP: Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study. Atherosclerosis. 2012, 223: 468-472.CrossRefPubMed
23.
go back to reference Alberti KG, Eckel RH, Grundy SM: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645.CrossRefPubMed Alberti KG, Eckel RH, Grundy SM: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645.CrossRefPubMed
24.
go back to reference Corrado E, Rizzo M, Novo S: Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke. 2006, 37: 482-486.CrossRefPubMed Corrado E, Rizzo M, Novo S: Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke. 2006, 37: 482-486.CrossRefPubMed
25.
go back to reference Salonen R, Haapanen A, Salonen JT: Measurement of intima media thickness of common carotid arteries with high resolution B-mode ultrasonography: inter- and intra-observer variability. Ultrasound Med Biol. 1991, 17: 225-230.CrossRefPubMed Salonen R, Haapanen A, Salonen JT: Measurement of intima media thickness of common carotid arteries with high resolution B-mode ultrasonography: inter- and intra-observer variability. Ultrasound Med Biol. 1991, 17: 225-230.CrossRefPubMed
26.
go back to reference Bots ML, Grobbee DE: Intima Media Thickness as a Surrogate Marker for Generalized Atherosclerosis. Cardiovasc Drugs Therapy. 2002, 16: 341-351.CrossRef Bots ML, Grobbee DE: Intima Media Thickness as a Surrogate Marker for Generalized Atherosclerosis. Cardiovasc Drugs Therapy. 2002, 16: 341-351.CrossRef
27.
go back to reference Crouse JR, Goldbourt U, Evans G: Risk Factors and Segment-Specific Carotid Arterial Enlargement in the Atherosclerosis Risk in Communities (ARIC) Cohort. Stroke. 1996, 27: 69-75.CrossRefPubMed Crouse JR, Goldbourt U, Evans G: Risk Factors and Segment-Specific Carotid Arterial Enlargement in the Atherosclerosis Risk in Communities (ARIC) Cohort. Stroke. 1996, 27: 69-75.CrossRefPubMed
28.
go back to reference Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation. 1997, 96: 1432-1437.CrossRefPubMed Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation. 1997, 96: 1432-1437.CrossRefPubMed
29.
go back to reference O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SKJ: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. Ann Internal Med. 1999, 340: 14-22. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SKJ: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. Ann Internal Med. 1999, 340: 14-22.
30.
go back to reference Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS, Study BH: Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (the Bogalusa heart study). Am J Cardiol. 2002, 90: 953-958.CrossRefPubMed Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS, Study BH: Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (the Bogalusa heart study). Am J Cardiol. 2002, 90: 953-958.CrossRefPubMed
31.
go back to reference Salonen JT, Salonen R: Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993, 87: 156-165. Salonen JT, Salonen R: Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993, 87: 156-165.
32.
go back to reference Rathsman B, Rosfors S, Sjöholm A, Nyström T: Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes. Cardiovasc Diabetol. 2012, 11: 145.PubMedCentralCrossRefPubMed Rathsman B, Rosfors S, Sjöholm A, Nyström T: Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes. Cardiovasc Diabetol. 2012, 11: 145.PubMedCentralCrossRefPubMed
33.
go back to reference Sousa MA, Guimarães IC, Daltro C, Guimarães AC: Association between birth weight and cardiovascular risk factors in adolescents. Arq Bras Cardiol. 2013, 101: 9-17.PubMedCentralPubMed Sousa MA, Guimarães IC, Daltro C, Guimarães AC: Association between birth weight and cardiovascular risk factors in adolescents. Arq Bras Cardiol. 2013, 101: 9-17.PubMedCentralPubMed
34.
go back to reference Freire CM, Barbosa FB, de Almeida MC, Miranda PA, Barbosa MM, Nogueira AI, Guimarães MM, Nunes Mdo C, Ribeiro-Oliveira A: Previous gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome - a case control study. Cardiovasc Diabetol. 2012, 11: 59.PubMedCentralCrossRefPubMed Freire CM, Barbosa FB, de Almeida MC, Miranda PA, Barbosa MM, Nogueira AI, Guimarães MM, Nunes Mdo C, Ribeiro-Oliveira A: Previous gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome - a case control study. Cardiovasc Diabetol. 2012, 11: 59.PubMedCentralCrossRefPubMed
35.
go back to reference Johnsen SH, Mathiesen EB, Joakimsen O: Carotid atherosclerosis is a stronger predictor of myocardial infarction in study women than in Men: a 6-year follow-up study of 6226 persons: the tromso. Stroke. 2007, 38: 2873-2880.CrossRefPubMed Johnsen SH, Mathiesen EB, Joakimsen O: Carotid atherosclerosis is a stronger predictor of myocardial infarction in study women than in Men: a 6-year follow-up study of 6226 persons: the tromso. Stroke. 2007, 38: 2873-2880.CrossRefPubMed
36.
go back to reference Rizzo M, Corrado E, Novo S: Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis. 2008, 200: 389-395.CrossRefPubMed Rizzo M, Corrado E, Novo S: Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis. 2008, 200: 389-395.CrossRefPubMed
37.
go back to reference Novo S, Visconti CL, Amoroso GR: Asymptomatic carotid lesions add to CV risk prediction. Eur J Cardiovasc Prev Rehabil. 2010, 17: 514-518.CrossRefPubMed Novo S, Visconti CL, Amoroso GR: Asymptomatic carotid lesions add to CV risk prediction. Eur J Cardiovasc Prev Rehabil. 2010, 17: 514-518.CrossRefPubMed
38.
go back to reference Birdsill AC, Carlsson CM, Willette AA, Okonkwo OC, Johnson SC, Xu G, Oh JM, Gallagher CL, Koscik RL, Jonaitis EM, Hermann BP, Larue A, Rowley HA, Asthana S, Sager MA, Bendlin BB: Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity (Silver Spring). 2013, 21: 1313-1320.CrossRef Birdsill AC, Carlsson CM, Willette AA, Okonkwo OC, Johnson SC, Xu G, Oh JM, Gallagher CL, Koscik RL, Jonaitis EM, Hermann BP, Larue A, Rowley HA, Asthana S, Sager MA, Bendlin BB: Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity (Silver Spring). 2013, 21: 1313-1320.CrossRef
39.
go back to reference Baldassare D, Hamsten A, Veglia F: IMPROVE Study Group. Measurements of Carotid Intima- Media thickness and of Interadventitia Common Carotid Diameter Improve Prediction of Cardiovascular Events: Results of the IMPROVE (Carotid Intima Media Thickness and IMT progression as Predictors of vascular events in a high risk European Population) Study. J Am Coll Cardiol. 2012, 60: 1489-1499.CrossRef Baldassare D, Hamsten A, Veglia F: IMPROVE Study Group. Measurements of Carotid Intima- Media thickness and of Interadventitia Common Carotid Diameter Improve Prediction of Cardiovascular Events: Results of the IMPROVE (Carotid Intima Media Thickness and IMT progression as Predictors of vascular events in a high risk European Population) Study. J Am Coll Cardiol. 2012, 60: 1489-1499.CrossRef
40.
go back to reference Nambi V, Chambless L, Folsom AR: Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (atherosclerosis Risk in Communities) study. J Am Coll Cardiol. 2010, 13 (55): 1600-1607.CrossRef Nambi V, Chambless L, Folsom AR: Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (atherosclerosis Risk in Communities) study. J Am Coll Cardiol. 2010, 13 (55): 1600-1607.CrossRef
41.
go back to reference Sehestedt T, Jeppesen J, Hansen TW: Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010, 31: 883-891.CrossRefPubMed Sehestedt T, Jeppesen J, Hansen TW: Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010, 31: 883-891.CrossRefPubMed
42.
go back to reference Mookadam F, Moustafa SE, Lester SJ, Warsame T: Subclinical atherosclerosis: evolving role of carotid intima-media thickness. Prev Cardiol. 2010, 13: 186-197.CrossRefPubMed Mookadam F, Moustafa SE, Lester SJ, Warsame T: Subclinical atherosclerosis: evolving role of carotid intima-media thickness. Prev Cardiol. 2010, 13: 186-197.CrossRefPubMed
43.
go back to reference European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol. 2012, 19: 585-667. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol. 2012, 19: 585-667.
44.
go back to reference Herder M, Arntzen KA, Johnsen SH, Mathiesen EB: The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study. Cardiovasc Diabetol. 2012, 11: 77.PubMedCentralCrossRefPubMed Herder M, Arntzen KA, Johnsen SH, Mathiesen EB: The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study. Cardiovasc Diabetol. 2012, 11: 77.PubMedCentralCrossRefPubMed
45.
go back to reference Novo S, Carità P, Corrado E: Preclinical carotid atherosclerosis enhances the global cardiovascular risk and increases the rate of cerebro- and cardiovascular events in a five-year follow-up. Atherosclerosis. 2010, 211: 287-290.CrossRefPubMed Novo S, Carità P, Corrado E: Preclinical carotid atherosclerosis enhances the global cardiovascular risk and increases the rate of cerebro- and cardiovascular events in a five-year follow-up. Atherosclerosis. 2010, 211: 287-290.CrossRefPubMed
46.
go back to reference Laaksonen DE, Lakka HM, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA: Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care. 2002, 25: 1612-1618.CrossRefPubMed Laaksonen DE, Lakka HM, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA: Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care. 2002, 25: 1612-1618.CrossRefPubMed
47.
go back to reference Shah PK: Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we?. J Am Coll Cardiol. 2010, 56: 98-105.CrossRefPubMed Shah PK: Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we?. J Am Coll Cardiol. 2010, 56: 98-105.CrossRefPubMed
Metadata
Title
Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up
Authors
Salvatore Novo
Angelica Peritore
Rosaria Linda Trovato
Francesco Paolo Guarneri
Daniela Di Lisi
Ida Muratori
Giuseppina Novo
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2013
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-12-155

Other articles of this Issue 1/2013

Cardiovascular Diabetology 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.